We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » St. Jude Results Reflect Troubled 2012, But Atrial Fib Sales Shine
St. Jude Results Reflect Troubled 2012, But Atrial Fib Sales Shine
January 25, 2013
St. Jude Medical expects less than half of its 2013 income to come from cardiac rhythm management (CRM) sales, due to an ongoing global slowdown in the market for cardiac devices, CEO Dan Starks said in a Tuesday earnings call.